methotrexate has been researched along with Pneumonia, Pneumococcal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Certan, M; Garcia Garrido, HM; Goorhuis, A; Grobusch, MP; Heijmans, J; Wong, G | 1 |
| Bengtsson, AA; Johansson, Å; Jönsson, G; Kapetanovic, MC; Nived, P; Pettersson, Å; Settergren, B; Skattum, L | 1 |
| Akazawa, M; Akeda, Y; Fukui, T; Furukawa, H; Hamada, N; Hirano, F; Ideguchi, H; Iwanaga, N; Izumi, Y; Jiuchi, Y; Kawabe, Y; Komiya, Y; Kozuru, H; Matsui, T; Matsumori, A; Matsumura, R; Migita, K; Miyamura, T; Mori, N; Mori, S; Ohshima, S; Oishi, K; Ozawa, T; Saisyo, K; Suematsu, E; Suenaga, Y; Takahi, K; Tohma, S; Tsutani, H; Yamanaka, T; Yoshizawa, S | 1 |
| Akazawa, M; Akeda, Y; Fukui, T; Furukawa, H; Hamada, N; Hirano, F; Ideguchi, H; Iwanaga, N; Izumi, Y; Jiuchi, Y; Kawabata, M; Kawakami, K; Kitagawa, K; Kozuru, H; Matsui, T; Matsumori, A; Matsumura, R; Migita, K; Miyamura, T; Mori, N; Mori, S; Nagai, H; Nakajima, K; Ohshima, S; Oishi, K; Ozawa, T; Saisyo, K; Suematsu, E; Suenaga, Y; Takahi, K; Tamura, N; Tohma, S; Tsutani, H; Yamanaka, T | 1 |
| Geborek, P; Kapetanovic, MC; Nagel, J; Nordström, I; Rudin, A; Saxne, T | 1 |
| Coulson, E; Hamilton, J; Heycock, C; Kelly, C; Long, KS; Morgan, L; Rynne, M; Saravanan, V; So, KL | 1 |
| Geborek, P; Jönsson, G; Kapetanovic, MC; Roseman, C; Saxne, T; Truedsson, L | 1 |
| Beiderlinden, M; Peters, J; Zimmer, C | 1 |
| Brezinschek, HP; Graninger, WB; Haindl, P; Hofstaetter, T; Leeb, BF | 1 |
1 review(s) available for methotrexate and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Methotrexate; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Tumor Necrosis Factor-alpha; Viral Vaccines; Virus Diseases | 2008 |
3 trial(s) available for methotrexate and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.
Topics: Abatacept; Aged; Antibodies, Bacterial; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Humoral; Male; Methotrexate; Middle Aged; Pneumococcal Vaccines; Pneumonia, Pneumococcal | 2015 |
Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.
Topics: Aged; Antibodies, Monoclonal; Antibody Formation; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Monitoring; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Serogroup; Streptococcus pneumoniae; Treatment Outcome | 2015 |
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibody Formation; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Spondylarthropathies; Streptococcus pneumoniae; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
5 other study(ies) available for methotrexate and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Cohort Studies; Community-Acquired Infections; Disease Progression; Female; Hematologic Neoplasms; Hospitalization; Humans; Incidence; Lenalidomide; Male; Methotrexate; Pneumonia; Pneumonia, Pneumococcal; Rituximab; Thalidomide | 2022 |
Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Bacterial; Antibody Formation; Antirheumatic Agents; Arthritis, Rheumatoid; B-Lymphocytes; Case-Control Studies; Female; Humans; Male; Methotrexate; Middle Aged; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vaccination | 2021 |
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Topics: Adult; Aged; Antibodies, Bacterial; Antirheumatic Agents; Arthritis, Rheumatoid; B-Lymphocytes; Enzyme-Linked Immunospot Assay; Female; Humans; Immunoglobulin A; Immunoglobulin G; Lymphocyte Count; Male; Methotrexate; Middle Aged; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Serogroup; Streptococcus pneumoniae; Vaccines, Conjugate | 2017 |
Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate.
Topics: Aged; Antibodies, Bacterial; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Opportunistic Infections; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vaccination | 2011 |
Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Community-Acquired Infections; Drug Therapy, Combination; Etanercept; Fatal Outcome; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Middle Aged; Pneumonia, Pneumococcal; Prednisolone; Receptors, Tumor Necrosis Factor; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha | 2006 |